Insider Trading & Ownership - Readnour Robin Shane

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Readnour Robin Shane
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-12
Sale
2024-01-17
5:03 pm
AN2 Therapeutics Inc.ANTXReadnour Robin Shane
Director
1,425$21.91$31,229485,073
(Indirect)
View
2024-01-10
Sale
2024-01-12
5:08 pm
AN2 Therapeutics Inc.ANTXReadnour Robin Shane
Director
3,669$21.93$80,443485,792
(Indirect)
View
2022-03-29
Purchase
2022-03-31
8:15 pm
AN2 Therapeutics Inc.ANTXReadnour Robin Shane
Director
153,334$15$2,300,010487,592
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-19
Option Award
2024-06-21
6:22 pm
N/A
2034-06-18
AN2 Therapeutics Inc.ANTXReadnour Robin Shane
Director
64,503$064,503
(Direct)
View
2023-06-07
Option Award
2023-06-09
8:33 pm
N/A
2033-06-06
AN2 Therapeutics Inc.ANTXReadnour Robin Shane
Director
23,742$023,742
(Direct)
View
2022-05-12
Option Award
2022-05-16
9:25 pm
N/A
2032-05-11
AN2 Therapeutics Inc.ANTXReadnour Robin Shane
Director
20,724$020,724
(Direct)
View
2022-03-29
Conversion
2022-03-31
8:15 pm
N/A
N/A
AN2 Therapeutics Inc.ANTXReadnour Robin Shane
Director
751,621$0487,592
(Indirect)
View

Ownership
2022-03-24
9:21 pm
N/A
N/A
AN2 Therapeutics Inc.ANTXReadnour Robin Shane
Director
0$0751,621
(Indirect)
View